CH
ELOX

CVI Holdings’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

CVI Holdings’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,860
Closed -$742K – 71
2019
Q2 		$742K Buy
+1,860
New +$783K 0.86% 21

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CVI Holdings's ELOX Position: Q3 2019 in Review

CVI Holdings sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q3 2019, closing a stake of 1,860 shares — an estimated $742K sold.

CVI Holdings first reported a position in ELOX in Q2 2019 and held it in 1 quarter. The position peaked at $742K in Q2 2019. 48 funds tracked by Wall St. Rank hold ELOX as of Q3 2019.

  • CVI Holdings reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • CVI Holdings sold 1,860 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $742K.
  • CVI Holdings first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • CVI Holdings's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $742K in Q2 2019.
  • 48 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on CVI Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.